Mechanisms that link the oncogenic epithelial-mesenchymal transition to suppression of anoikis.
about
Anti-Cancer Stem-like Cell Compounds in Clinical Development - An Overview and Critical AppraisalFAK in cancer: mechanistic findings and clinical applicationsP53- and mevalonate pathway-driven malignancies require Arf6 for metastasis and drug resistance.Pseudomonas aeruginosa ExoT Induces Atypical Anoikis Apoptosis in Target Host Cells by Transforming Crk Adaptor Protein into a CytotoxinRegulation of Wnt/β-catenin signaling by herpesvirusesDisruptive environmental chemicals and cellular mechanisms that confer resistance to cell deathMiR-424-5p reversed epithelial-mesenchymal transition of anchorage-independent HCC cells by directly targeting ICAT and suppressed HCC progressionGrainyhead-like 2 Reverses the Metabolic Changes Induced by the Oncogenic Epithelial-Mesenchymal Transition: Effects on AnoikisEpithelial-mesenchymal transition and tumor suppression are controlled by a reciprocal feedback loop between ZEB1 and Grainyhead-like-2Lipid tethering of breast tumor cells enables real-time imaging of free-floating cell dynamics and drug response.Protein Kinase C-ε Promotes EMT in Breast Cancer.BRD4 promotes p63 and GRHL3 expression downstream of FOXO in mammary epithelial cellsPathobiological implications of the d16HER2 splice variant for stemness and aggressiveness of HER2-positive breast cancer.Aiolos promotes anchorage independence by silencing p66Shc transcription in cancer cells.Neoadjuvant sorafenib treatment of clear cell renal cell carcinoma and release of circulating tumor fragments.NDRG2 overexpression enhances glucose deprivation-mediated apoptosis in breast cancer cells via inhibition of the LKB1-AMPK pathway.Activation of Lyn tyrosine kinase through decreased membrane cholesterol levels during a change in its membrane distribution upon cell detachment.The Warburg effect in tumor progression: mitochondrial oxidative metabolism as an anti-metastasis mechanismHigh focal adhesion kinase expression in breast carcinoma is associated with lymphovascular invasion and triple-negative phenotype.Epithelial-mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients.Upregulation of TrkB promotes epithelial-mesenchymal transition and anoikis resistance in endometrial carcinoma.Clinical implications of circulating tumor cells of breast cancer patients: role of epithelial-mesenchymal plasticityParaquat induces epithelial-mesenchymal transition-like cellular response resulting in fibrogenesis and the prevention of apoptosis in human pulmonary epithelial cells.Tumor-secreted Hsp90 subverts polycomb function to drive prostate tumor growth and invasion.Pharmacokinetic analysis of the FAK scaffold inhibitor C4 in dogsCan we safely target the WNT pathway?Transforming growth factor-β1 induces EMT by the transactivation of epidermal growth factor signaling through HA/CD44 in lung and breast cancer cellsReprogramming during epithelial to mesenchymal transition under the control of TGFβPrognostic Value of Focal Adhesion Kinase (FAK) in Human Solid Carcinomas: A Meta-Analysis.The Anoikis Effector Bit1 Inhibits EMT through Attenuation of TLE1-Mediated Repression of E-Cadherin in Lung Cancer Cells.A FAK scaffold inhibitor disrupts FAK and VEGFR-3 signaling and blocks melanoma growth by targeting both tumor and endothelial cellsNegative feedback loop between p66Shc and ZEB1 regulates fibrotic EMT response in lung cancer cellsRegulation of anoikis by deleted in breast cancer-1 (DBC1) through NF-κB.Anti-Müllerian Hormone Signaling Regulates Epithelial Plasticity and Chemoresistance in Lung Cancer.ZEB1 induces EPB41L5 in the cancer mesenchymal program that drives ARF6-based invasion, metastasis and drug resistance.Insufficient radiofrequency ablation promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells through Akt and ERK signaling pathways.An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530).Interplay of Stem Cell Characteristics, EMT, and Microtentacles in Circulating Breast Tumor Cells.Interferon-induced transmembrane protein 1 (IFITM1) is required for the progression of colorectal cancer.The RESOLVE concept: approaching pathophysiology of fibroproliferative disease in aged individuals.
P2860
Q26744536-2F14B40D-8BEF-4ACE-BB46-EF63DAF8DB8FQ27026533-B1EE768B-AD40-4560-8022-99109F37AAB5Q27308938-9B66F6FA-9E44-4575-BE5B-2F0B0A1D253DQ27319429-84C4F9F4-0CF1-4A1C-8700-846D0C38D0E5Q28079414-929D0CFF-B95C-489B-AC73-AE8957541310Q28080874-6E5520E5-C4DB-4A3A-A579-0D8308465849Q28393361-500EE43E-4437-45DA-AD0F-80AC2C186BA6Q28397162-6249553B-E75E-487F-9E38-A47FA99EE125Q28662207-6F5633D7-FEBA-44C0-84D3-5F1BE1D74193Q30380965-5E6131C2-6AE3-41CE-847C-44BE000606E4Q30413942-BE6D1880-5337-4CF0-92C7-0BA40B52640FQ33557475-C7AE0AFF-B2DB-4079-B2DB-1AE364AF4588Q33737058-CC958AFF-FA3A-45D0-A347-B48DFBBA37A8Q33806421-53C3086F-DE10-4270-885C-BD25EE0A5FC9Q33891216-B0E64464-72BF-4041-90D3-9C0446CC6CEBQ33925325-91DD7193-7988-4671-8FC7-13F4E60C6757Q34248998-5EE22FDA-2BCB-4DEC-A4C6-A5F4AC358F51Q34332654-5AFC28BE-7556-44B8-B8DB-9F67101FDAB6Q34423151-C21D2215-F5F0-49F9-B67C-88476FD7FB00Q34880376-A6BFEF93-D587-4350-8A77-79844DFBF80BQ34923263-969D1A2A-9E13-43FA-A2F4-606F56CBA2DAQ35124176-6D828B01-1628-4AAF-A1C5-BAF5AA4108BCQ35208873-3064FFF5-8450-4FB2-AE20-768426569A3EQ35221554-C94267F4-04A9-4B53-9461-EA65ECB5225EQ35582654-ECCF26D9-1630-4648-9828-90972E8B4160Q35591995-DB076EA1-2955-4C2D-91C6-826430897ACCQ35827597-1A6E3D43-3121-4689-A657-A3BD47BC9C93Q36124946-D1FEB6D5-76DF-4F50-9B35-16B03F425FACQ36135842-2A86BAFF-ADC2-41D8-B9FD-89AC0961AFC6Q36140142-622F83A7-4987-4D7C-9805-948921FC620AQ36188833-CC5A2BBD-6FF0-4EE6-85E5-08A0573DD554Q36293264-9288ECBA-B72D-4FB9-AF7A-55B4913487C3Q36951585-C5710817-C051-4C83-A8E7-35138AD00C63Q37116060-65F9E25E-6F79-4EE0-B2D0-3818005330DEQ37306553-FDFAE60C-43AA-4F84-9E11-DCC7B33DE2BDQ37348249-058FDBAF-93C4-4B18-9A40-D286BD78BF12Q37357076-8C0EB8B9-1A55-417A-9214-85545CB806C0Q37420601-20553565-50F4-422F-AA17-3193B1D6CF49Q37699175-53EB3E3D-3DB8-4521-AB40-BED246F6979DQ38129218-253A8466-998F-45FF-B7A2-7205724AD048
P2860
Mechanisms that link the oncogenic epithelial-mesenchymal transition to suppression of anoikis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Mechanisms that link the oncog ...... ion to suppression of anoikis.
@ast
Mechanisms that link the oncog ...... ion to suppression of anoikis.
@en
type
label
Mechanisms that link the oncog ...... ion to suppression of anoikis.
@ast
Mechanisms that link the oncog ...... ion to suppression of anoikis.
@en
prefLabel
Mechanisms that link the oncog ...... ion to suppression of anoikis.
@ast
Mechanisms that link the oncog ...... ion to suppression of anoikis.
@en
P2093
P2860
P356
P1476
Mechanisms that link the oncog ...... ion to suppression of anoikis.
@en
P2093
Benjamin Cieply
Michael Schaller
Steven M Frisch
P2860
P356
10.1242/JCS.120907
P407
P577
2013-01-01T00:00:00Z